Review points to nanoparticles and nasal delivery as possible routes past Alzheimer's drug barriers
In short: Researchers reviewing the state of Alzheimer's disease treatment found that current drugs only ease symptoms, since getting medicines past the blood-brain barrier remains a major obstacle. They highlight soft nanoparticles, including nanoliposomes and exosomes, as an emerging approach that early studies suggest could help carry treatments into brain tissue, alongside intranasal delivery as another promising route.
This is a literature review, not a new clinical trial: the authors synthesise existing research on Alzheimer's risk factors, prevention, and treatment limitations, noting that no disease-modifying treatment yet exists. Because nanoparticle and intranasal strategies are still being tested rather than used in patients, the review frames them as promising research directions rather than established treatments.
Why it matters: Getting Alzheimer's treatments into the brain remains a major challenge, and researchers are exploring new delivery methods as possible solutions.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Source: Research: Passeri et al. (2022). Alzheimer’s Disease: Treatment Strategies and Their Limitations. International Journal of Molecular Sciences. · cc-by
To cite this card, link to https://intellectplus.co.uk/app/health-research-nanoparticles-and-nasal-delivery-may-help-overcome-barriers.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health · Latest · A–Z · All topics
